![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 5224 |
FusionGeneSummary for CACNB1_CDC6 |
![]() |
Fusion gene information | Fusion gene name: CACNB1_CDC6 | Fusion gene ID: 5224 | Hgene | Tgene | Gene symbol | CACNB1 | CDC6 | Gene ID | 782 | 990 |
Gene name | calcium voltage-gated channel auxiliary subunit beta 1 | cell division cycle 6 | |
Synonyms | CAB1|CACNLB1|CCHLB1 | CDC18L|HsCDC18|HsCDC6|MGORS5 | |
Cytomap | 17q12 | 17q21.2 | |
Type of gene | protein-coding | protein-coding | |
Description | voltage-dependent L-type calcium channel subunit beta-1calcium channel voltage-dependent subunit beta 1calcium channel, L type, beta 1 polypeptidecalcium channel, voltage-dependent, beta 1 subunitdihydropyridine-sensitive L-type, calcium channel beta- | cell division control protein 6 homologCDC6 cell division cycle 6 homologCDC6-related proteincdc18-related proteincell division cycle 6 homologp62(cdc6) | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | Q02641 | Q99741 | |
Ensembl transtripts involved in fusion gene | ENST00000394303, ENST00000394310, ENST00000344140, ENST00000582877, | ENST00000209728, | |
Fusion gene scores | * DoF score | 13 X 8 X 3=312 | 8 X 4 X 7=224 |
# samples | 12 | 9 | |
** MAII score | log2(12/312*10)=-1.37851162325373 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(9/224*10)=-1.31550182572793 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: CACNB1 [Title/Abstract] AND CDC6 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | CDC6 | GO:0051984 | positive regulation of chromosome segregation | 21041660 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | BRCA | TCGA-AR-A0TX-01A | CACNB1 | chr17 | 37351137 | - | CDC6 | chr17 | 38445660 | + |
TCGA | LD | BRCA | TCGA-BH-A0B7-01A | CACNB1 | chr17 | 37351137 | - | CDC6 | chr17 | 38457080 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-5UTR | ENST00000394303 | ENST00000209728 | CACNB1 | chr17 | 37351137 | - | CDC6 | chr17 | 38445660 | + |
5CDS-5UTR | ENST00000394310 | ENST00000209728 | CACNB1 | chr17 | 37351137 | - | CDC6 | chr17 | 38445660 | + |
5CDS-5UTR | ENST00000344140 | ENST00000209728 | CACNB1 | chr17 | 37351137 | - | CDC6 | chr17 | 38445660 | + |
5UTR-5UTR | ENST00000582877 | ENST00000209728 | CACNB1 | chr17 | 37351137 | - | CDC6 | chr17 | 38445660 | + |
Frame-shift | ENST00000394303 | ENST00000209728 | CACNB1 | chr17 | 37351137 | - | CDC6 | chr17 | 38457080 | + |
Frame-shift | ENST00000394310 | ENST00000209728 | CACNB1 | chr17 | 37351137 | - | CDC6 | chr17 | 38457080 | + |
Frame-shift | ENST00000344140 | ENST00000209728 | CACNB1 | chr17 | 37351137 | - | CDC6 | chr17 | 38457080 | + |
5UTR-3CDS | ENST00000582877 | ENST00000209728 | CACNB1 | chr17 | 37351137 | - | CDC6 | chr17 | 38457080 | + |
Top |
FusionProtFeatures for CACNB1_CDC6 |
![]() |
Hgene | Tgene |
CACNB1 | CDC6 |
The beta subunit of voltage-dependent calcium channelscontributes to the function of the calcium channel by increasingpeak calcium current, shifting the voltage dependencies ofactivation and inactivation, modulating G protein inhibition andcontrolling the alpha-1 subunit membrane targeting. | Involved in the initiation of DNA replication. Alsoparticipates in checkpoint controls that ensure DNA replication iscompleted before mitosis is initiated. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for CACNB1_CDC6 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for CACNB1_CDC6 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
CACNB1 | NEDD4L, ATN1, APP, SRPK1, CACNB2, CACNB3, C19orf26, KLHL15, WDR75 | CDC6 | PPP2R3B, ORC2, ORC1, MCM7, PSKH1, CCNA2, MYC, CDK2, PCNA, MCM3, AKAP8L, PPP2R3A, CDT1, MCM8, HUWE1, TERF1, ATR, ATM, ATRIP, BMI1, KAT7, CCL2, FZR1, CDC20, CDK4, CDK6, MCM10, MCM2, ORC5, ORC3, ORC6, CDKN2A, CDKN1A, CCNE1, CCNB1, CDK1, B3GALNT1, UBE2K, CDC14A, UBR1, TSPAN3, COLEC11, TGFBR2, ISLR, PON2, POLA1, NOP56, CCNF, LAMP2, IL20RA, TNFRSF1A, FAM131B, PROZ, MANSC1, PCDHB11, TNFRSF10A, LAMP3, BPNT1, C1orf85, TNFRSF8, MAGEA10, PCDHGA5, CHEK2, CHEK1, TOP1, TOP2A, TOP3A, WEE1, HEY1 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CACNB1_CDC6 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | CACNB1 | Q02641 | DB00308 | Ibutilide | Voltage-dependent L-type calcium channel subunit beta-1 | small molecule | approved |
Hgene | CACNB1 | Q02641 | DB00661 | Verapamil | Voltage-dependent L-type calcium channel subunit beta-1 | small molecule | approved |
Hgene | CACNB1 | Q02641 | DB00898 | Ethanol | Voltage-dependent L-type calcium channel subunit beta-1 | small molecule | approved |
Hgene | CACNB1 | Q02641 | DB04855 | Dronedarone | Voltage-dependent L-type calcium channel subunit beta-1 | small molecule | approved |
Hgene | CACNB1 | Q02641 | DB00393 | Nimodipine | Voltage-dependent L-type calcium channel subunit beta-1 | small molecule | approved|investigational |
Hgene | CACNB1 | Q02641 | DB00653 | Magnesium sulfate | Voltage-dependent L-type calcium channel subunit beta-1 | small molecule | approved|investigational|vet_approved |
Top |
RelatedDiseases for CACNB1_CDC6 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | CDC6 | C0032460 | Polycystic Ovary Syndrome | 1 | CTD_human |
Tgene | CDC6 | C1868684 | EAR, PATELLA, SHORT STATURE SYNDROME | 1 | CTD_human;ORPHANET |
Tgene | CDC6 | C3151126 | MEIER-GORLIN SYNDROME 5 | 1 | UNIPROT |